Free Webinar | Post-Pandemic: How are You Changing Your Strategy for Digital Transformation in Clinical Trials?

September 28, 2021 | 11:00 am – 12:00 pm EDT


In the pre-pandemic world, clinical research organizations were faced with segmented technologies and complex workflows which extended trial timelines and increased costs, compelling the need for digital transformation.

Sponsors and CROs alike continue to search for a way to transform their infrastructure and operationalize data while remaining compliant, so that they can rapidly return to focusing on clinical development and putting people and patients first.  But with the new knowledge of the past year, what changes will they make to their strategy?


  • Learn about advancing strategies for implementing digital trials and DCT
  • Hear techniques on how to move from pilots and one off studies for digital trials and DCT
  • Gain insight into ways to ensure the success of your digital trials, through best practices for people, process, and data


This panel discussion will benefit these executives:

  • Professionals seeking further knowledge on how to develop their digital strategy for clinical trials
  • Director, VP level, and Executive Management
  • Clinical Operations and Innovations


David Blackman

David Blackman
Executive Director Digital Trials Strategy, Oracle Health Sciences

As Oracle’s Executive Director Digital Trials Strategy, David Blackman has responsibility for aligning digital strategies and innovations with Oracle’s developing business needs. Within his role in Oracle’s Health Sciences Global Businesses Unit, David is responsible for creating and developing differentiating technology and business capabilities through development, partnerships and acquisitions that enhance clinical trial research and accelerate bringing drugs to market for our clients.

Before joining Oracle in 2021, he served in the Corporate Development and Strategy group at PPD where he had responsibility for PPDs business innovation, leading and incubated cutting-edge business solutions resulting in the investment, development, integration and commercialization of digital and remote clinical trials capabilities. Prior to that David worked at IBM/Lenovo, where he held a number of global technology and business leadership roles.

Bryan Hill

Bryan Hill
Vice President Digital Health & Innovation, CTO, Cognizant

Bryan Hill is Chief Technology Officer and Vice President, Digital Health & Innovation within Cognizant's Life Sciences Practice. He is responsible for shaping Cognizant’s full suite of digital capabilities and technology innovation into offerings that enable client organizations to better connect humans to their health and deliver business value. His team collaborates closely with clients and industry partners to enable transformation across the value chain in areas such as clinical development, patient engagement strategies, and digital therapeutics.

A recognized thought leader on topics such as digital trends, emerging technologies and product design, Bryan has more than 25 years of experience in software development, digital communications, marketing, user experience and management consulting. He is a founding member of Cadient, Cognizant’s digital agency focused on life sciences. Bryan recently served as an advisor to Brown University’s Executive Master in Science and Technology Leadership program.

Prior to Cadient and Cognizant, Bryan was a product development leader for cloud-based enterprise strategy management startup ActiveStrategy. His background also includes time as a digital practice leader with IQGroup, a management and IT consulting firm.

Rasmus Hogreffe

Rasmus Hogreffe, MSc.Med., MBA
Vice President of DCT Innovation, Medable

Rasmus Hogreffe, MSc.Med., MBA is considered as a Decentralized Clinical Trial Expert. He is the VP of Decentralized Clinical Trial Innovation at Medable. Before joining Medable he was the head of Virtual Clinical Trials at LEO Innovation Lab.

His main goal is to improve treatment for patients by making trials better and faster than ever before, using digital and remote innovations.

He holds an Executive MBA and a Master in Medical Science (MSc. Medicine) and has, since 2010, been working in the healthcare industry in various positions within clinical research & development. Rasmus has extensive experience in the pharmaceutical industry and has been involved in more than 60 clinical trials, giving him a broad knowledge regarding every aspect of clinical research.

Furthermore, Rasmus is a serial entrepreneur and has a successful record of starting and selling companies within his broad scope of interests: Digitalization of clinical trials, Patient recruitment, Real World Data, and Health innovation.

In addition, as an external lecturer and supervisor at Aalborg University, Rasmus has developed and given courses and workshops on management of clinical studies on topics such as the development of recruitment and retention strategies, site-optimization, site-selection and patient engagement to sponsors, investigators and study teams at leading medical centers.

His innovative approach within the field of digital health, Patient Recruitment, and Virtual Clinical Trials make him a frequently used chairman and speaker.


Jim Streeter

Jim Streeter
Global Vice President Life Science Customer Success, Oracle Health Sciences

As the global head of life sciences product strategy for Oracle, Jim collaborates closely with Oracle customers, regulatory agencies, analysts, and industry thought leaders to develop and help execute the overall business and product strategy for Oracle Health Sciences. He previously held leadership roles at PPD in both operations and IT. Jim has 30 years of data acquisition and analysis experience utilizing computerized systems and has focused on eClinical systems and processes for trials for the last 20 years. Jim's experience includes implementing end to end eClinical Solutions and processes across all therapeutic areas and all phases of studies.



As a leader in Life Sciences cloud technology, Oracle Health Sciences’ Clinical One and Safety One are trusted globally by professionals in both large and emerging companies engaged in clinical research and pharmacovigilance. With over 20 years’ experience, Oracle Health Sciences is committed to supporting clinical development, delivering innovation to accelerate advancements, and empowering the Life Sciences industry to improve patient outcomes. Oracle Health Sciences. For life. Learn more at


SCOPE Summit Europe